BR112022009804A2 - Tratamento profilático da pele para radioterapia - Google Patents
Tratamento profilático da pele para radioterapiaInfo
- Publication number
- BR112022009804A2 BR112022009804A2 BR112022009804A BR112022009804A BR112022009804A2 BR 112022009804 A2 BR112022009804 A2 BR 112022009804A2 BR 112022009804 A BR112022009804 A BR 112022009804A BR 112022009804 A BR112022009804 A BR 112022009804A BR 112022009804 A2 BR112022009804 A2 BR 112022009804A2
- Authority
- BR
- Brazil
- Prior art keywords
- radiotherapy
- prophylatic
- skin treatment
- skin
- treatment
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 3
- 238000001959 radiotherapy Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010050207 Skin fibrosis Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962938209P | 2019-11-20 | 2019-11-20 | |
| PCT/US2020/056421 WO2021101646A1 (en) | 2019-11-20 | 2020-10-20 | Prophylactic skin treatment for radiation therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022009804A2 true BR112022009804A2 (pt) | 2022-08-16 |
Family
ID=75980773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022009804A BR112022009804A2 (pt) | 2019-11-20 | 2020-10-20 | Tratamento profilático da pele para radioterapia |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12403106B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4061402A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023503283A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115279394A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022009804A2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021101646A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025111378A1 (en) * | 2023-11-20 | 2025-05-30 | Tautona Group Ip Holding Company, L.L.C. | Semi-solid formulations of deferoxamine for the treatment of radiation therapy burns |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE26914C (de) | 1883-06-19 | 1884-05-08 | CH E. SACKETT in Wayne-Township, Pennsylvanien, V. St. A | Ackergeräth zum Pflügen und Zerkleinern der Erde |
| DK1585548T3 (en) | 2002-12-09 | 2018-09-03 | Abraxis Bioscience Llc | COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS |
| US7618615B2 (en) | 2004-08-13 | 2009-11-17 | Healthpartners Research Foundation | Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia |
| WO2006034128A2 (en) | 2004-09-17 | 2006-03-30 | Angiotech Biomaterials Corporation | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
| WO2006078717A2 (en) * | 2005-01-19 | 2006-07-27 | Beth Israel Deaconess Medical Center | Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis |
| EP3725324A1 (en) | 2005-09-16 | 2020-10-21 | Cornell Research Foundation, Inc. | Aromatic-cationic peptide for use in a method for reducing cd36 expression |
| US20100068279A1 (en) | 2006-11-28 | 2010-03-18 | Ats Biotech Inc. | Burn bandage |
| US20090069623A1 (en) * | 2007-08-21 | 2009-03-12 | Virginia Commonwealth University Intellectual Property Foundation | Methods and compositions for treatment or prevention of radiation-induced fibrosis |
| US20090198332A1 (en) | 2008-02-05 | 2009-08-06 | Hilton Becker | Method for texturing the surface of a synthetic implant |
| US10098857B2 (en) * | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
| EP3189836B1 (en) | 2009-08-19 | 2024-01-17 | Mordechai Chevion | Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| US8377062B2 (en) | 2009-12-17 | 2013-02-19 | Stryker Trauma Gmbh | Therapeutic agent capsule for implants |
| EP2793966B1 (en) | 2011-12-22 | 2018-03-28 | Centre Hospitalier Universitaire Vaudois (CHUV) | Selective plasma activation for medical implants and wound healing devices |
| US9737395B2 (en) | 2015-06-26 | 2017-08-22 | Phi Nguyen | Systems and methods for reducing scarring |
| US10933174B2 (en) | 2016-05-03 | 2021-03-02 | Medtronic, Inc. | Hemostatic devices and methods of use |
-
2020
- 2020-10-20 JP JP2022529271A patent/JP2023503283A/ja active Pending
- 2020-10-20 EP EP20889325.5A patent/EP4061402A4/en active Pending
- 2020-10-20 WO PCT/US2020/056421 patent/WO2021101646A1/en not_active Ceased
- 2020-10-20 US US17/778,802 patent/US12403106B2/en active Active
- 2020-10-20 CN CN202080093822.2A patent/CN115279394A/zh active Pending
- 2020-10-20 BR BR112022009804A patent/BR112022009804A2/pt unknown
-
2025
- 2025-03-04 JP JP2025033377A patent/JP2025084944A/ja active Pending
- 2025-07-15 US US19/270,093 patent/US20250375400A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021101646A1 (en) | 2021-05-27 |
| US20220409559A1 (en) | 2022-12-29 |
| JP2023503283A (ja) | 2023-01-27 |
| EP4061402A4 (en) | 2023-12-06 |
| EP4061402A1 (en) | 2022-09-28 |
| JP2025084944A (ja) | 2025-06-03 |
| US20250375400A1 (en) | 2025-12-11 |
| CN115279394A (zh) | 2022-11-01 |
| US12403106B2 (en) | 2025-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023001527A (es) | Compuestos con actividad inductora de ferroptosis y metodos de uso de estos. | |
| CR20120638A (es) | Métodos de terapia combinada para tratar enfermedades proliferativas | |
| BR112022000019A2 (pt) | Composto da fórmula, composição farmacêutica e método de tratamento de câncer | |
| MX2021013830A (es) | Inhibidores de ezh2 para tratar linfomas. | |
| BR112021018739A2 (pt) | Composições e métodos para o tratamento de doenças ou distúrbios associados a kras | |
| MX2019005465A (es) | Metodo de tratamiento de un tumor inmunoterapeutico. | |
| BR112019005930A2 (pt) | combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas | |
| BR112016012713A2 (pt) | Método para tratamento de câncer em um paciente necessitado, e, método de selecionar um paciente para um método de tratamento | |
| MX2021006734A (es) | Metodo para tratar el cancer. | |
| BR112018005592A8 (pt) | Dispositivos e métodos para aprimorar a aplicação tópica de um agente de benefício | |
| BR112017007975A2 (pt) | composições e métodos para o tratamento de disfunção das glândulas meibomianas | |
| SV2017005380A (es) | Tratamientos conjuntos con anticuerpos anti cd40 | |
| BR112017015059A2 (pt) | inibidor de proteassoma e uso | |
| BR112021017616A2 (pt) | Conjugado de derivado de anticorpo anti-her2-pirrolobenzodiazepina | |
| BR112018001640A2 (pt) | combinação de antagonista da pd-1 com um inibidor de egfr | |
| BR112016029334A2 (pt) | produto farmacêutico, uso de um anticorpo, kit, método para tratar um paciente com câncer e métodos e usos de novos produtos | |
| MX2014000555A (es) | Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos. | |
| BR112018006039A2 (pt) | terapia adjuvante com 25-hidroxivitamina d e artigos para a mesma | |
| BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
| BR112019022280A2 (pt) | tratamento de cânceres de her2 positivo | |
| CL2020002465A1 (es) | Método de tratamiento de enfermedad fibrótica | |
| BR112017009552A8 (pt) | Métodos para alvejar o controle transcricional em regiões de super-realçador | |
| BR112015026247A2 (pt) | métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor | |
| MX2019003722A (es) | Composiciones inmunogénicas de tert y métodos de tratamiento que las utilizan. | |
| MX2021003006A (es) | Bacterioterapia contra proprionibacterium acnes para el tratamiento de acne. |